LXEO · Lexeo Therapeutics, Inc.
Market Cap
$398.74M
Shares
82.05M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-29 | Lexeo Therapeutics Stifel Virtual Fireside Chat | Webcast |
| 2026-06-15 | Regulatory Update of LX2006 for the Treatment of Friedrich Ataxia Cardiomyopathy | Webcast |
| 2026-05-19 | 2026 RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-03-10 | Leerink Global Healthcare Conference | Conference |
| 2026-02-26 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-02-12 | Guggenheim Emerging Outlook: Biotech Summit 2026 | Webcast |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2026-01-12 | Interim Clinical Data from the Phase 1/2 HEROIC-PKP2 Trial of LX2020 for Arrhythmogenic Cardiomyopathy Caused by Mutations in the PKP2 Gene | Earnings call |
Source: https://ir.lexeotx.com/
Key facts
CIK
1907108
CUSIP
52886X107
13F (30d)
128 filings
122 filers
Visit website
Investor relations